Osteopontin-targeted monoclonal antibodies (Pfizer)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameOsteopontin-targeted monoclonal antibodies (Pfizer)
Drug Alias NameMOR-6991MOR-6990MOR-6993
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionOsteopontin antagonists
TargetsOsteopontin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A